GlycoBac's patented glycoprotein production technology is unique within the biotechnology industry. GlycoBac provides a proven, versatile and fully scalable higher eukaryotic production platform.

GlycoBac developed technology to produce glycoproteins with precise control over their sugar structures using glycoengineered insect cells and baculoviral vectors.

Our cell lines and baculoviral vectors allow for the production of glycoproteins with custom designed glycans, allowing the biopharmaceutical industry to find the optimal sugar structures that maximize therapeutic efficacy.

These tools are also available for researchers worldwide to investigate the biological impact of different glycan structures on protein function.

GlycoBac - the Glycoengineers